Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13297-18-2

Post Buying Request

13297-18-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13297-18-2 Usage

General Description

The chemical 2-(ethoxycarbonyl)-3-methylquinoxalinediium-1,4-diolate is a compound with potential biological and pharmaceutical applications. It is a quinoxaline derivative that contains a diol and diium group. Quinoxaline compounds have been studied for their potential anticancer, antiviral, and antimicrobial properties. The presence of the ethoxycarbonyl and methyl groups in this compound may contribute to its potential biological activity. Further research and testing are necessary to fully understand the properties and potential uses of this chemical compound.

Check Digit Verification of cas no

The CAS Registry Mumber 13297-18-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,9 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13297-18:
(7*1)+(6*3)+(5*2)+(4*9)+(3*7)+(2*1)+(1*8)=102
102 % 10 = 2
So 13297-18-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O4/c1-3-18-12(15)11-8(2)13(16)9-6-4-5-7-10(9)14(11)17/h4-7H,3H2,1-2H3

13297-18-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-carboxylate

1.2 Other means of identification

Product number -
Other names 2-ethoxycarbonyl-3-methylquinoxaline di-N-oxide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13297-18-2 SDS

13297-18-2Relevant articles and documents

Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents

Jaso, Andrés,Zarranz, Belén,Aldana, Ignacio,Monge, Antonio

, p. 2019 - 2025 (2005)

Twenty-nine new 6(7)-substituted quinoxaline-2-carboxylate 1,4-dioxide derivatives were synthesized and evaluated for in vitro antituberculosis activity. In general, the in vitro activity is significantly affected by substituents on the quinoxaline nucleu

SYNTHESIS, CRYSTAL AND MOLECULAR STRUCTURES OF 2-METHYL-3-CARBOETHOXYQUINOXALINE 1,4-DIOXIDE

Lin, Shu-Kun,Cong, Qiu-Zhi

, p. 279 - 286 (1987)

2-Methyl-3-carboethoxyquinoxaline 1,4-dioxide (MCQO) was prepered and single crystals were grown out of the reaction mixture.The structure of MCQO was established by single-crystal X-ray crystallography using a direct method.The crystals are triclinic, space group P, with a = 6.928(1), b = 8.109(1), c = 10.552(1) angstroem, α = 83.445(8), β = 85.681(10), γ = 79.168(8) deg, V = 577.7 angstroem3, Z = 2 and Dc = 1.428 g cm-3.The structure was refined to R = 0.059 for 1454 reflections.The planar geometry of the parent quinoxaline ring is consistent with the aromaticity of the condensed heterocyclic system in the compound.The average N-O bond length is 1.297(5) angstroem, indicating a certain double-bond character.The X-ray analysis corroborates IR, NMR, and ESR spectroscopic evidence for the structure of this type of heteroaromatic N-oxides.

Combining metabolite-based pharmacophores with Bayesian machine learning models for mycobacterium tuberculosis drug discovery

Ekins, Sean,Madrid, Peter B.,Sarker, Malabika,Li, Shao-Gang,Mittal, Nisha,Kumar, Pradeep,Wang, Xin,Stratton, Thomas P.,Zimmerman, Matthew,Talcott, Carolyn,Bourbon, Pauline,Travers, Mike,Yadav, Maneesh,Freundlich, Joel S.

, (2015/12/26)

Integrated computational approaches for Mycobacterium tuberculosis (Mtb) are useful to identify new molecules that could lead to future tuberculosis (TB) drugs. Our approach uses information derived from the TBCyc pathway and genome database, the Collabor

Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates

Romeiro, Nelilma C.,Aguirre, Gabriela,Hernandez, Paola,Gonzalez, Mercedes,Cerecetto, Hugo,Aldana, Ignacio,Perez-Silanes, Silvia,Monge, Antonio,Barreiro, Eliezer J.,Lima, Lidia M.

experimental part, p. 641 - 652 (2009/08/07)

In this paper, we report the structural design, synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazone (NAH) derivatives, planned as cruzain inhibitors candidates, a cysteine protease essential for the survival of Trypan

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13297-18-2